SynthesisCancer medicine2024

Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta-analysis.

Danzhu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.